ABCB1, ABCC1, and LRP gene expressions are altered by LDL, HDL, and serum deprivation in a human doxorubicin-resistant uterine sarcoma cell line

Biochemical and Biophysical Research Communications

Volumn 457, Issue 4, 2015, Pages 664-668

  Celestino, Andréa Turbuck ^a   Levy, Débora ^a   Maria Ruiz, Jorge Luis ^a   Bydlowski, Sérgio Paulo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ABCB1; ABCC1; Lipoproteins; LRP; Multiple drug resistance

Indexed keywords

DOXORUBICIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; ANTINEOPLASTIC ANTIBIOTIC; HIGH DENSITY LIPOPROTEIN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; RIBONUCLEOPROTEIN;

ARTICLE; CANCER RESISTANCE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DRUG TRANSPORT; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; NEOPLASM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SARCOMA CELL LINE; UTERUS SARCOMA; BLOOD; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SARCOMA; TUMOR CELL LINE; UTERINE NEOPLASMS; UTERUS;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEINS; SARCOMA; UTERINE NEOPLASMS; UTERUS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 84922687705     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.01.045     Document Type: Article

References (38)

1. L. Gayet, G. Dayan, S. Barakat, S. Labialle, M. Michaud, S. Cogne, A. Mazane, A.W. Coleman, D. Rigal, and L.G. Baggetto Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells Biochemistry 44 2005 4499 4509
2. S.V. Ambudkar, C. Kimchi-Sarfaty, Z.E. Sauna, and M.M. Gottesman P-glycoprotein: from genomics to mechanism Oncogene 22 2003 7468 7485
3. J.L. Ruiz, L.R. Fernandes, D. Levy, and S.P. Bydlowski Interrelationship between ATP-binding cassette transporters and oxysterols Biochem. Pharmacol. 86 2013 80 88
4. A. Rothnie, D. Theron, L. Soceneantu, C. Martin, M. Traikia, G. Berridge, C.F. Higgins, P.F. Devaux, and R. Callaghan The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence Eur. Biophys. J. 30 2001 430 442
5. Z. Bacso, H. Nagy, K. Goda, L. Bene, F. Fenyvesi, J. Matko, and G. Szabo Raft and cytoskeleton associations of an ABC transporter: P-glycoprotein Cytom. A 61 2004 105 116
6. S. Orlowski, S. Martin, and A. Escargueil P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?) Cell. Mol. Life Sci. 63 2006 1038 1059
7. J. Troost, N. Albermann, W. Emil Haefeli, and J. Weiss Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells Biochem. Biophys. Res. Commun. 316 2004 705 711
8. S.P. Cole, G. Bhardwaj, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M. Duncan, and R.G. Deeley Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 258 1992 1650 1654
9. E. Bakos, and L. Homolya Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1) Pflugers Arch. 453 2007 621 641
10. M. Munoz, M. Henderson, M. Haber, and M. Norris Role of the MRP1/ABCC1 multidrug transporter protein in cancer IUBMB Life 59 2007 752 757
11. M.H. Mossink, A. van Zon, R.J. Scheper, P. Sonneveld, and E.A. Wiemer Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22 2003 7458 7467
12. P.D. Eckford, and F.J. Sharom Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport Biochemistry 47 2008 13686 13698
13. A. Garrigues, A.E. Escargueil, and S. Orlowski The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane Proc. Natl. Acad. Sci. U S A 99 2002 10347 10352
14. D. Levy, J.L. Ruiz, A.T. Celestino, S.F. Silva, A.K. Ferreira, C. Isaac, and S.P. Bydlowski Short-term effects of 7-ketocholesterol on human adipose tissue mesenchymal stem cells in vitro Biochem. Biophys. Res. Commun. 446 2014 720 725
15. S.P. Bydlowski, R.L. Yunker, and M.T. Subbiah Ontogeny of 6-keto-PGF1 alpha synthesis in rabbit aorta and the effect of premature weaning Am. J. Physiol. 252 1987 H14 H21
16. V.T. Hungria, M.C. Latrilha, D.G. Rodrigues, S.P. Bydlowski, C.S. Chiattone, and R.C. Maranhao Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease Cancer Chemother. Pharmacol. 53 2004 51 60
17. Y. Shu, and H. Liu Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line Biochem. Cell. Biol. 85 2007 638 646
18. L. Connelly-Smith, J. Pattinson, M. Grundy, S. Shang, C. Seedhouse, N. Russell, and M. Pallis P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors Exp. Hematol. 35 2007 1793 1800
19. D.J. Sprinkle, Z. Rymaszewski, S. Bydlowski, C. Stevens, R. Yunker, and M.T. Subbiah Studies on aorta during development. II. Differences in ontogeny of the key enzymes involved in cholesteryl ester synthesis and hydrolysis in rabbit aorta Atherosclerosis 67 1987 71 80
20. J.E. Metherall, H. Li, and K. Waugh Role of multidrug resistance P-glycoproteins in cholesterol biosynthesis J. Biol. Chem. 271 1996 2634 2640
21. P. Debry, E.A. Nash, D.W. Neklason, and J.E. Metherall Role of multidrug resistance P-glycoproteins in cholesterol esterification J. Biol. Chem. 272 1997 1026 1031
22. F.J. Field, E. Born, S. Murthy, and S.N. Mathur Transport of cholesterol from the endoplasmic reticulum to the plasma membrane is constitutive in CaCo-2 cells and differs from the transport of plasma membrane cholesterol to the endoplasmic reticulum J. Lipid Res. 39 1998 333 343
23. W. Le Goff, M. Settle, D.J. Greene, R.E. Morton, and J.D. Smith Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis J. Lipid Res. 47 2006 51 58
24. F.A. Sinicrope, P.K. Dudeja, B.M. Bissonnette, A.R. Safa, and T.A. Brasitus Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles J. Biol. Chem. 267 1992 24995 25002
25. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
26. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
27. W.G. Harker, and B.I. Sikic Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA Cancer Res. 45 1985 4091 4096
28. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
29. S.W. Kamau, S.D. Kramer, M. Gunthert, and H. Wunderli-Allenspach Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells In Vitro Cell. Dev. Biol. Anim. 41 2005 207 216
30. F.J. Sharom Complex interplay between the P-glycoprotein multidrug efflux pump and the membrane: its role in modulating protein function Front. Oncol. 4 2014 41
31. Y. Lavie, G. Fiucci, and M. Liscovitch Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells J. Biol. Chem. 273 1998 32380 32383
32. M. Liscovitch, and Y. Lavie Multidrug resistance: a role for cholesterol efflux pathways? Trends Biochem. Sci. 25 2000 530 534
33. I. Bosch, K. Dunussi-Joannopoulos, R.L. Wu, S.T. Furlong, and J. Croop Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein Biochemistry 36 1997 5685 5694
34. A. Pohl, H. Lage, P. Muller, T. Pomorski, and A. Herrmann Transport of phosphatidylserine via MDR1 (multidrug resistance 1)P-glycoprotein in a human gastric carcinoma cell line Biochem. J. 365 2002 259 268
35. E. Wang, C.N. Casciano, R.P. Clement, and W.W. Johnson Cholesterol interaction with the daunorubicin binding site of P-glycoprotein Biochem. Biophys. Res. Commun. 276 2000 909 916
36. J. Troost, H. Lindenmaier, W.E. Haefeli, and J. Weiss Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells Mol. Pharmacol. 66 2004 1332 1339
37. G.D. Luker, C.M. Pica, A.S. Kumar, D.F. Covey, and D. Piwnica-Worms Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains Biochemistry 39 2000 8692
38. F. Fenyvesi, E. Fenyvesi, L. Szente, K. Goda, Z. Bacso, I. Bacskay, J. Varadi, T. Kiss, E. Molnar, T. Janaky, G. Szabo Jr., and M. Vecsernyes P-glycoprotein inhibition by membrane cholesterol modulation Eur. J. Pharm. Sci. 34 2008 236 242